Clinical Trials

A clinical trial is a research study that tries to find better ways to prevent, screen for, diagnose, or treat a disease like bladder cancer.  They are an essential part of cancer research.  Trials may provide possible treatment alternatives to patients who have not had success with standard and approved therapies.

Why you consider a clinical trial to treat your bladder cancer

Here are several reasons bladder cancer patients should consider participating in a clinical trial:

  • Access to cutting-edge bladder cancer treatments: By participating, you may access effective or advanced treatment options that are not yet available to everyone. These treatments may have better results than the standard of care or existing therapies and could improve their chances of successful outcomes.
  • Contribute to medical advancement: Bladder cancer patients play a vital role in helping researchers understand the disease better. Clinical trials help develop new therapies, and enhance existing ones, which can benefit future generations who may be diagnosed with bladder cancer.
  • Close monitoring and care: Patients in clinical trials receive close medical supervision and monitoring. This level of attention can lead to better management of side effects and complications, ensuring the patient’s safety and well-being throughout the trial.
  • Hope for a cure or extended life: For some bladder cancer patients, clinical trials offer the hope of finding a cure or extending their life when conventional treatments have not been effective.

Bladder cancer patients should talk with their healthcare team, to determine whether a clinical trial is an option for their specific situation. They should carefully weigh the potential benefits and risks, ensuring they make an informed decision about their treatment plan.

You can search for a clinical trial below by bladder cancer disease state, state of residence and you can also look for trials nearest to you.

About Clinical Trials

To help find trials near you, you need to allow BCAN to access your location
Ok

Title State Sponsoring Organization
Study of BA3071 Multi-State BioAtla, Inc.
Intravesical PPM Therapy for NMIBC Massachusetts VA Office of Research and Development
CLEAR Care Companion Application Michigan University of Michigan Rogel Cancer Center
Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors Multi-State Tyra Biosciences, Inc
68Gallium PSMA-PET/CT Scans in People With Bladder Cancer New York Memorial Sloan Kettering Cancer Center
AU-011 (Belzupacap Sarotalocan) in NMIBC Multi-State Aura Biosciences
ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma Multi-State Acrivon Therapeutics
A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder Multi-State Janssen Research & Development, LLC
Pembrolizumab in MIBC Multi-State Matthew Galsky

Learn more about the different phases clinical trials here.